{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T17:43:31Z","timestamp":1776620611334,"version":"3.51.2"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2017,12,1]]},"DOI":"10.1001\/jamadermatol.2017.3593","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T12:31:49Z","timestamp":1507120309000},"page":"1302","source":"Crossref","is-referenced-by-count":36,"title":["Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis"],"prefix":"10.1001","volume":"153","author":[{"given":"Daniel J.","family":"Lewis","sequence":"first","affiliation":[{"name":"School of Medicine, Baylor College of Medicine, Houston, Texas"},{"name":"Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakhshandra","family":"Talpur","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auris O.","family":"Huen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T.","family":"Tetzlaff","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston"},{"name":"Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeleine","family":"Duvic","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2017.3593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T12:31:34Z","timestamp":1513168294000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2017.3593"}},"subtitle":["An Analysis of Phase 2 Results"],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2017.3593","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12,1]]}}}